Page last updated: 2024-08-24

3-iodobenzylguanidine and furosemide

3-iodobenzylguanidine has been researched along with furosemide in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chikama, H; Demachi, J; Goto, A; Ikeda, J; Li, S; Sekiguchi, Y; Shirato, K; Takita, T	1
Ichikawa, S; Ishikawa, T; Kasama, S; Kumakura, H; Kurabayashi, M; Suzuki, T; Takayama, Y; Toyama, T	1
Fujimoto, S; Hisatake, S; Nakano, H; Namiki, A; Nanjo, S; Yamashina, S; Yamazaki, J; Yuzawa, H	1
Ideguchi, T; Ishikawa, T; Kitamura, K; Koyama, S; Nagamachi, S; Onitsuka, H	1

Trials

2 trial(s) available for 3-iodobenzylguanidine and furosemide

Article	Year
Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity in patients with decompensated congestive heart failure. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004, Volume: 45, Issue:7 Topics: 3-Iodobenzylguanidine; Aged; Atrial Natriuretic Factor; Cardiotonic Agents; Dopamine; Drug Combinations; Female; Furosemide; Heart; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sympathetic Nervous System; Treatment Outcome; Ventricular Dysfunction, Left	2004
Comparative analysis of the therapeutic effects of long-acting and short-acting loop diuretics in the treatment of chronic heart failure using (123)I-metaiodobenzylguanidine scintigraphy. European journal of heart failure, 2011, Volume: 13, Issue:8 Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Chronic Disease; Cross-Over Studies; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sodium Potassium Chloride Symporter Inhibitors; Sulfanilamides	2011

Article

Year

Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity in patients with decompensated congestive heart failure.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004, Volume: 45, Issue:7

Topics: 3-Iodobenzylguanidine; Aged; Atrial Natriuretic Factor; Cardiotonic Agents; Dopamine; Drug Combinations; Female; Furosemide; Heart; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sympathetic Nervous System; Treatment Outcome; Ventricular Dysfunction, Left

2004

Comparative analysis of the therapeutic effects of long-acting and short-acting loop diuretics in the treatment of chronic heart failure using (123)I-metaiodobenzylguanidine scintigraphy.

European journal of heart failure, 2011, Volume: 13, Issue:8

Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Chronic Disease; Cross-Over Studies; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sodium Potassium Chloride Symporter Inhibitors; Sulfanilamides

2011

Other Studies

2 other study(ies) available for 3-iodobenzylguanidine and furosemide

Article	Year
[Evaluation of therapy for dilated cardiomyopathy with heart failure by iodine-123 metaiodobenzylguanidine imaging: comparison with heart rate variability power spectral analysis]. Journal of cardiology, 1998, Volume: 32, Issue:5 Topics: 3-Iodobenzylguanidine; Angiotensin-Converting Enzyme Inhibitors; Cardiomyopathy, Dilated; Cardiotonic Agents; Digoxin; Diuretics; Enalapril; Female; Furosemide; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Ventricular Function, Left	1998
Impact of short-acting loop diuretic doses and cardiac sympathetic nerve abnormalities on outcomes of patients with reduced left ventricular function. Medicine, 2019, Volume: 98, Issue:8 Topics: 3-Iodobenzylguanidine; Aged; Biological Availability; Dose-Response Relationship, Drug; Female; Furosemide; Heart; Heart Failure; Humans; Japan; Male; Middle Aged; Myocardial Perfusion Imaging; Outcome and Process Assessment, Health Care; Radiopharmaceuticals; Sodium Potassium Chloride Symporter Inhibitors; Stroke Volume; Sympathetic Nervous System; Ventricular Dysfunction, Left	2019

Article

Year

[Evaluation of therapy for dilated cardiomyopathy with heart failure by iodine-123 metaiodobenzylguanidine imaging: comparison with heart rate variability power spectral analysis].

Journal of cardiology, 1998, Volume: 32, Issue:5

Topics: 3-Iodobenzylguanidine; Angiotensin-Converting Enzyme Inhibitors; Cardiomyopathy, Dilated; Cardiotonic Agents; Digoxin; Diuretics; Enalapril; Female; Furosemide; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Ventricular Function, Left

1998

Impact of short-acting loop diuretic doses and cardiac sympathetic nerve abnormalities on outcomes of patients with reduced left ventricular function.

Medicine, 2019, Volume: 98, Issue:8

Topics: 3-Iodobenzylguanidine; Aged; Biological Availability; Dose-Response Relationship, Drug; Female; Furosemide; Heart; Heart Failure; Humans; Japan; Male; Middle Aged; Myocardial Perfusion Imaging; Outcome and Process Assessment, Health Care; Radiopharmaceuticals; Sodium Potassium Chloride Symporter Inhibitors; Stroke Volume; Sympathetic Nervous System; Ventricular Dysfunction, Left

2019